Comparison of surgical outcomes between small collagen and chromic catgut implants in deep sclerectomy.

I. H. Shin, Young Soo Nah, Young Jae Hong, chanyun kim

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

In deep sclerectomy, collagen implant has been used to maintain space under the scleral flap. However, the effect of other implants has not been studied. In this retrospective study, we compared surgical outcomes between small collagen and chromic catgut used as implants in deep sclerectomy. Deep sclerectomy was performed on 23 patients (25 eyes) who either had an open angle and a high intraocular pressure (IOP) (> 22 mmHg) in spite of receiving the maximal tolerable medical treatment, or who were intolerant to medications. Our study consisted of 14 patients (15 eyes) in the small collagen group and 8 (9 eyes) in the chromic catgut group. The mean follow-up period was 8.6 +/- 3.3 months in the small collagen group and 4.4 +/- 1.2 months in the chromic catgut group. The mean preoperative IOP was not significantly different between the two groups. The complete success rate of the small collagen group was significantly better than that of the chromic catgut group at the final follow-up when data were analyzed using the Kaplan-Meier survival curve (87% versus 30%; P = .01). As for the qualified success rate, the small collagen group showed significantly better results at the final follow-up (93% versus 80%; P = .046). The mean number of postoperative medications was significantly lower in the small collagen group (0.26 versus 1.10; P < .05). These results confirmed that the use of small collagen implant in deep sclerectomy produced a higher success rate and a lowered need for postoperative medication compared to the use of chromic catgut implant. Because equal sized implants were used, the difference in biochemical properties, particularly the severity of inflammation caused by the implant, is presumed to be the cause of the different surgical outcomes.

Original languageEnglish
Pages (from-to)75-81
Number of pages7
JournalKorean journal of ophthalmology : KJO
Volume16
Issue number2
DOIs
Publication statusPublished - 2002 Jan 1

Fingerprint

Catgut
Collagen
Intraocular Pressure
Kaplan-Meier Estimate
Retrospective Studies
Inflammation

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

@article{75915e58f923455cbd1738f1ebbfc282,
title = "Comparison of surgical outcomes between small collagen and chromic catgut implants in deep sclerectomy.",
abstract = "In deep sclerectomy, collagen implant has been used to maintain space under the scleral flap. However, the effect of other implants has not been studied. In this retrospective study, we compared surgical outcomes between small collagen and chromic catgut used as implants in deep sclerectomy. Deep sclerectomy was performed on 23 patients (25 eyes) who either had an open angle and a high intraocular pressure (IOP) (> 22 mmHg) in spite of receiving the maximal tolerable medical treatment, or who were intolerant to medications. Our study consisted of 14 patients (15 eyes) in the small collagen group and 8 (9 eyes) in the chromic catgut group. The mean follow-up period was 8.6 +/- 3.3 months in the small collagen group and 4.4 +/- 1.2 months in the chromic catgut group. The mean preoperative IOP was not significantly different between the two groups. The complete success rate of the small collagen group was significantly better than that of the chromic catgut group at the final follow-up when data were analyzed using the Kaplan-Meier survival curve (87{\%} versus 30{\%}; P = .01). As for the qualified success rate, the small collagen group showed significantly better results at the final follow-up (93{\%} versus 80{\%}; P = .046). The mean number of postoperative medications was significantly lower in the small collagen group (0.26 versus 1.10; P < .05). These results confirmed that the use of small collagen implant in deep sclerectomy produced a higher success rate and a lowered need for postoperative medication compared to the use of chromic catgut implant. Because equal sized implants were used, the difference in biochemical properties, particularly the severity of inflammation caused by the implant, is presumed to be the cause of the different surgical outcomes.",
author = "Shin, {I. H.} and Nah, {Young Soo} and Hong, {Young Jae} and chanyun kim",
year = "2002",
month = "1",
day = "1",
doi = "10.3341/kjo.2002.16.2.75",
language = "English",
volume = "16",
pages = "75--81",
journal = "Korean journal of ophthalmology : KJO",
issn = "1011-8942",
publisher = "Seoul Kjo",
number = "2",

}

Comparison of surgical outcomes between small collagen and chromic catgut implants in deep sclerectomy. / Shin, I. H.; Nah, Young Soo; Hong, Young Jae; kim, chanyun.

In: Korean journal of ophthalmology : KJO, Vol. 16, No. 2, 01.01.2002, p. 75-81.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Comparison of surgical outcomes between small collagen and chromic catgut implants in deep sclerectomy.

AU - Shin, I. H.

AU - Nah, Young Soo

AU - Hong, Young Jae

AU - kim, chanyun

PY - 2002/1/1

Y1 - 2002/1/1

N2 - In deep sclerectomy, collagen implant has been used to maintain space under the scleral flap. However, the effect of other implants has not been studied. In this retrospective study, we compared surgical outcomes between small collagen and chromic catgut used as implants in deep sclerectomy. Deep sclerectomy was performed on 23 patients (25 eyes) who either had an open angle and a high intraocular pressure (IOP) (> 22 mmHg) in spite of receiving the maximal tolerable medical treatment, or who were intolerant to medications. Our study consisted of 14 patients (15 eyes) in the small collagen group and 8 (9 eyes) in the chromic catgut group. The mean follow-up period was 8.6 +/- 3.3 months in the small collagen group and 4.4 +/- 1.2 months in the chromic catgut group. The mean preoperative IOP was not significantly different between the two groups. The complete success rate of the small collagen group was significantly better than that of the chromic catgut group at the final follow-up when data were analyzed using the Kaplan-Meier survival curve (87% versus 30%; P = .01). As for the qualified success rate, the small collagen group showed significantly better results at the final follow-up (93% versus 80%; P = .046). The mean number of postoperative medications was significantly lower in the small collagen group (0.26 versus 1.10; P < .05). These results confirmed that the use of small collagen implant in deep sclerectomy produced a higher success rate and a lowered need for postoperative medication compared to the use of chromic catgut implant. Because equal sized implants were used, the difference in biochemical properties, particularly the severity of inflammation caused by the implant, is presumed to be the cause of the different surgical outcomes.

AB - In deep sclerectomy, collagen implant has been used to maintain space under the scleral flap. However, the effect of other implants has not been studied. In this retrospective study, we compared surgical outcomes between small collagen and chromic catgut used as implants in deep sclerectomy. Deep sclerectomy was performed on 23 patients (25 eyes) who either had an open angle and a high intraocular pressure (IOP) (> 22 mmHg) in spite of receiving the maximal tolerable medical treatment, or who were intolerant to medications. Our study consisted of 14 patients (15 eyes) in the small collagen group and 8 (9 eyes) in the chromic catgut group. The mean follow-up period was 8.6 +/- 3.3 months in the small collagen group and 4.4 +/- 1.2 months in the chromic catgut group. The mean preoperative IOP was not significantly different between the two groups. The complete success rate of the small collagen group was significantly better than that of the chromic catgut group at the final follow-up when data were analyzed using the Kaplan-Meier survival curve (87% versus 30%; P = .01). As for the qualified success rate, the small collagen group showed significantly better results at the final follow-up (93% versus 80%; P = .046). The mean number of postoperative medications was significantly lower in the small collagen group (0.26 versus 1.10; P < .05). These results confirmed that the use of small collagen implant in deep sclerectomy produced a higher success rate and a lowered need for postoperative medication compared to the use of chromic catgut implant. Because equal sized implants were used, the difference in biochemical properties, particularly the severity of inflammation caused by the implant, is presumed to be the cause of the different surgical outcomes.

UR - http://www.scopus.com/inward/record.url?scp=0036987831&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036987831&partnerID=8YFLogxK

U2 - 10.3341/kjo.2002.16.2.75

DO - 10.3341/kjo.2002.16.2.75

M3 - Article

C2 - 12546443

AN - SCOPUS:0036987831

VL - 16

SP - 75

EP - 81

JO - Korean journal of ophthalmology : KJO

JF - Korean journal of ophthalmology : KJO

SN - 1011-8942

IS - 2

ER -